Matthew Tagliaferro
About Matthew Tagliaferro
Matthew Tagliaferro is a Regional Business Director with extensive experience in the biotechnology and pharmaceuticals sectors. He has held various sales and account management positions across multiple companies, demonstrating a strong commitment to self-improvement and organizational goals.
Current Role at Secura Bio
Matthew Tagliaferro serves as the Regional Business Director at Secura Bio, Inc. since 2023. His role is based in the Greater Philadelphia area and is performed remotely. In this position, he focuses on driving business strategies and fostering relationships within the biotechnology sector.
Previous Experience in Biotechnology Sales
Matthew has extensive experience in biotechnology sales, having held various positions in notable companies. He worked at GRAIL, Inc. as a Sales Consultant for the Galleri product for seven months in 2021. Prior to that, he was a Senior Account Executive and Regional Field Trainer in Oncology at Ambry Genetics from 2021 to 2023, and held a similar role from 2018 to 2021. His expertise includes promoting Copiktra and a strong background in hospital sales.
Education and Academic Background
Matthew Tagliaferro completed his high school education at Boston College High School, earning his diploma from 1992 to 1996. He then attended Saint Anselm College, where he studied Biology and obtained a Bachelor of Arts degree from 1996 to 2000.
Sales and Account Management Experience
Matthew's career includes significant roles in sales and account management across various organizations. He worked as an Account Business Manager at PerkinElmer from 2008 to 2011 and as a Sr. Territory Account Manager at Illumina from 2011 to 2015. He also held positions at Eurofins as a Genetics Account Executive and at Sequenom as a Business Development Manager.
Commitment to Professional Development
Matthew demonstrates a commitment to self-improvement and achieving organizational goals. He emphasizes creative thinking and teamwork in his professional endeavors, which contributes to his effectiveness in the sales and biotechnology sectors.